Global Single-ingredient Codeine Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Single-ingredient Codeine Market Research Report 2024
Single-ingredient codeine is approved for pain management in adults only. Also used to reduce coughing. It is frequently combined with promethazine in prescription cough-and-cold medicines and with other cold remedies in over-the-counter (OTC) preparations.
According to Mr Accuracy reports’s new survey, global Single-ingredient Codeine market is projected to reach US$ 54 million in 2034, increasing from US$ 79 million in 2024, with the CAGR of -5.5% during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Single-ingredient Codeine market research.
Key manufacturers engaged in the Single-ingredient Codeine industry include Taiji, Mallinckrodt, TEVA, Johnson & Johnson, Medreich, Sanofi Aventis, Cipla, Hikma and Pharmaceutical Associates, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % volume of Single-ingredient Codeine were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Single-ingredient Codeine market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Single-ingredient Codeine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Taiji
Mallinckrodt
TEVA
Johnson & Johnson
Medreich
Sanofi Aventis
Cipla
Hikma
Pharmaceutical Associates
Novartis
Apotex
Mylan
Aristo Pharma GmbH
Lannett Company
Laboratoire Riva
Segment by Type
Ordinary Tablet
Sustained Release Tablets
Narcotic Analgesic
Antitussive
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Single-ingredient Codeine report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Single-ingredient Codeine market is projected to reach US$ 54 million in 2034, increasing from US$ 79 million in 2024, with the CAGR of -5.5% during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Single-ingredient Codeine market research.
Key manufacturers engaged in the Single-ingredient Codeine industry include Taiji, Mallinckrodt, TEVA, Johnson & Johnson, Medreich, Sanofi Aventis, Cipla, Hikma and Pharmaceutical Associates, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % volume of Single-ingredient Codeine were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Single-ingredient Codeine market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Single-ingredient Codeine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Taiji
Mallinckrodt
TEVA
Johnson & Johnson
Medreich
Sanofi Aventis
Cipla
Hikma
Pharmaceutical Associates
Novartis
Apotex
Mylan
Aristo Pharma GmbH
Lannett Company
Laboratoire Riva
Segment by Type
Ordinary Tablet
Sustained Release Tablets
Segment by Application
Narcotic Analgesic
Antitussive
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Single-ingredient Codeine report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source